Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Aptamers targeting SARS-COV-2: a promising tool to fight against COVID-19

1 Aug 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced biosensing and bioanalysis techniques
Share to Biosensors and Analytical Detection
Share to SARS-CoV-2 detection and testing

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35995601
DOI: 10.1016/j.tibtech.2022.07.012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Aptamers targeting SARS-COV-2: a promising tool to fight against COVID-19PMID 35995601Read ↗

Harnessing aptamers against COVID-19: A therapeutic strategySemantic proximity Read ↗

Clinical Translation of Aptamers for COVID-19Semantic proximity Read ↗

Aptamer‐based strategies against SARS‐CoV‐2 virusesSemantic proximity Read ↗

Rethinking Aptamers as Nanotheranostic Tools for SARS-COV-2 and COVID-19 InfectionSemantic proximity Read ↗

Cell delivery peptides for small interfering RNAs targeting SARS-CoV-2 new variants through a bioinformatics and deep learning designSemantic proximity Read ↗

Oligonucleotide aptamers for pathogen detection and infectious disease controlSemantic proximity Read ↗

Antisense oligonucleotide: A promising therapeutic option to beat COVID ‐19Semantic proximity Read ↗

Exploring the future of SARS-CoV-2 treatment after the first two years of the pandemic: A comparative study of alternative therapeuticsSemantic proximity Read ↗

Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?Semantic proximity Read ↗

Aptamers—Diagnostic and Therapeutic Solution in SARS-CoV-2Semantic proximity Read ↗

COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main proteaseSemantic proximity Read ↗

TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.